Acute coronary syndrome. Acute coronary
Conditions
Interventions
Intervention 1: Intervention Group: For patients in the intervention group, in addition to the routine training provided to all patients before discharge, the DaruYad medication-reminder application
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: Definite diagnosis of acute coronary syndrome for the first time, confirmed by a cardiologist. No major psychological disorders such as major depression, psychosis, etc. Willingness of the patient to participate in the research. Ability to read and write Ability to use a mobile phone and possession of a personal smartphone capable of installing the medication reminder application used in the present study. Ability to perform self-care activities, especially adherence to prescribed medications. Age between 35 and 65 years No hearing, vision, or other physical and sensory disabilities. No addiction to drugs, alcohol, or psychoactive substances. No memory-related disorders or dementia. No participation in other educational programs or self-care intervention studies. Patient’s acknowledgment of having adequate financial means or family/social support to obtain prescribed medications during the study period.
Exclusion criteria
Exclusion criteria: Recurrence of acute and severe symptoms of the disease or acute complications of coronary syndrome (such as dysrhythmias and various types of heart blocks) requiring rehospitalization in intensive care units. Development of cognitive or psychological disorders during the study. Patient’s unwillingness to continue participation in the study. Death of the patient. Occurrence of acute events or crises affecting medication adherence and the patient’s quality of life, such as severe trauma, death of first-degree relatives, and similar situations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication adherence. Timepoint: Before, immediately after the intervention, and two months after the intervention. Method of measurement: Morisky Medication Adherence Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before, immediately after the intervention, and two months after the intervention. Method of measurement: MacNew Heart Disease Health-related Quality of Life Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Fakharzadeh jahromi
Jahrom University of Medical Sciences
Outcome results
None listed